# OnCo record paper-okane-gata6-basal-like-compass-ccr-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-okane-gata6-basal-like-compass-ccr-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-okane-gata6-basal-like-compass-ccr-2020" ;
  schema:name "GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer"@en ;
  schema:description "In 195 patients treated with chemotherapy for advanced pancreatic cancer, one in five had the basal-like type; those patients responded a third as often, progressed on FOLFIRINOX four times as often and lived 5.9 rather than 9.3 months, and a simple GATA6 tissue stain picked the type out."@en ;
  schema:url <https://onco.cc/key-papers/paper-okane-gata6-basal-like-compass-ccr-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-19-3724>, <https://pubmed.ncbi.nlm.nih.gov/32156747/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-19-3724> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "O'Kane GM, Grunwald BT, Jang GH, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/> ;
  onco:institutions <https://onco.cc/institutions/princess-margaret/>, <https://onco.cc/institutions/oicr/> ;
  onco:pathways <https://onco.cc/pathways/epigenetic-reprogramming/> ;
  onco:terms <https://onco.cc/terms/ihc/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .